Literature DB >> 27557164

Systematic review of risk prediction models for diabetes after bariatric surgery.

R Zhang1, O Borisenko2, I Telegina1, J Hargreaves3, A R Ahmed4, R Sanchez Santos5, C Pring6, P Funch-Jensen7,8, B Dillemans9, J L Hedenbro10.   

Abstract

BACKGROUND: Diabetes remission is an important outcome after bariatric surgery. The purpose of this study was to identify risk prediction models of diabetes remission after bariatric surgery.
METHODS: A systematic literature review was performed in MEDLINE, MEDLINE-In-Process, Embase and the Cochrane Central Register of Controlled Trials databases in April 2015. All English-language full-text published derivation and validation studies for risk prediction models on diabetic outcomes after bariatric surgery were included. Data extraction included population, outcomes, variables, intervention, model discrimination and calibration.
RESULTS: Of 2330 studies retrieved, eight met the inclusion criteria. Of these, six presented development of risk prediction models and two reported validation of existing models. All included models were developed to predict diabetes remission. Internal validation using tenfold validation was reported for one model. Two models (ABCD score and DiaRem score) had external validation using independent patient cohorts with diabetes remission assessed at 12 and 14 months respectively. Of the 11 cohorts included in the eight studies, calibration was not reported in any cohort, and discrimination was reported in two.
CONCLUSION: A variety of models are available for predicting risk of diabetes following bariatric surgery, but only two have undergone external validation.
© 2016 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27557164     DOI: 10.1002/bjs.10255

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Health Care Institutions Volume Is Significantly Associated with Postoperative Outcomes in Bariatric Surgery.

Authors:  Laurent Brunaud; Stephanie Polazzi; Jean-Christophe Lifante; Lea Pascal; David Nocca; Antoine Duclos
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

2.  Validation of Ad-DiaRem and ABCD Diabetes Remission Prediction Scores at 1-Year After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in the Randomized Controlled Oseberg Trial.

Authors:  Farhat Fatima; Jøran Hjelmesæth; Jens Kristoffer Hertel; Marius Svanevik; Rune Sandbu; Milada Cvancarova Småstuen; Dag Hofsø
Journal:  Obes Surg       Date:  2022-01-04       Impact factor: 4.129

3.  Comparison of Preoperative Remission Scores and Diabetes Duration Alone as Predictors of Durable Type 2 Diabetes Remission and Risk of Diabetes Complications After Bariatric Surgery: A Post Hoc Analysis of Participants From the Swedish Obese Subjects Study.

Authors:  Kajsa Sjöholm; Lena M S Carlsson; Magdalena Taube; Carel W le Roux; Per-Arne Svensson; Markku Peltonen
Journal:  Diabetes Care       Date:  2020-09-01       Impact factor: 19.112

4.  Type 2 Diabetes Mellitus Remission Models Following Laparoscopic Gastric Bypass: a 4-Model Analysis in a Latino Population.

Authors:  Antonio Herrera; Andrés León; Fátima M Rodríguez; Elisa M Sepúlveda; Lizbeth Guilbert; Omar Quiroz; Luis Cevallos; Carlos Zerrweck
Journal:  Obes Surg       Date:  2020-08-17       Impact factor: 4.129

5.  Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy.

Authors:  Shih-Chiang Shen; Weu Wang; Ka-Wai Tam; Hsin-An Chen; Yen-Kuang Lin; Shih-Yun Wang; Ming-Te Huang; Yen-Hao Su
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

6.  Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass.

Authors:  Xabier Unamuno; Maitane Izaguirre; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Sara Becerril; Víctor Valentí; Rafael Moncada; Camilo Silva; Javier Salvador; Piero Portincasa; Gema Frühbeck; Victoria Catalán
Journal:  Nutrients       Date:  2019-09-03       Impact factor: 5.717

7.  Who will benefit from bariatric surgery for diabetes? A protocol for an observational cohort study.

Authors:  Julia S Kenkre; Ahmed R Ahmed; Sanjay Purkayastha; Khalefah Malallah; Stephen Bloom; Alexandra I Blakemore; A Toby Prevost; Tricia Tan
Journal:  BMJ Open       Date:  2021-02-10       Impact factor: 2.692

8.  The Choice of Gastric Bypass or Sleeve Gastrectomy for Patients Stratified by Diabetes Duration and Body Mass Index (BMI) level: Results from a National Registry and Meta-analysis.

Authors:  Mengyi Li; Na Zeng; Yang Liu; Wenmao Yan; Songhai Zhang; Liangping Wu; Shaozhuang Liu; Jun Wang; Xiangwen Zhao; Jianli Han; Jiansheng Kang; Nengwei Zhang; Peng Zhang; Rixing Bai; Zhongtao Zhang
Journal:  Obes Surg       Date:  2021-06-16       Impact factor: 4.129

Review 9.  Reversibility of diabetes mellitus: Narrative review of the evidence.

Authors:  Gary Yee Ang
Journal:  World J Diabetes       Date:  2018-07-15

10.  External validation of predictive scores for diabetes remission after metabolic surgery.

Authors:  Izabela A Karpińska; Joanna Choma; Michał Wysocki; Alicja Dudek; Piotr Małczak; Magdalena Szopa; Michał Pędziwiatr; Piotr Major
Journal:  Langenbecks Arch Surg       Date:  2021-07-13       Impact factor: 2.895

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.